Spaventa Andrew — SEC insider filings
SEC reporting owner CIK 1859701. 21 insider filings on record with FilingPulse; latest filed 2026-11-02.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2021-06-01 to 2026-11-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 118,468 shares, $49,612 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 1,850 shares, $37,377 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 71.
- Largest priced transaction: purchase of 75,000 shares @ $0.42 ($31,755) in Singular Genomics Systems, Inc., filed 2023-11-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Singular Genomics Systems, Inc. (OMIC) | Chief Executive Officer, Director | 19 | 2 legs · 118,468 sh · $49,612 | 4 legs · 1,850 sh · $37,377 | 67 |
| Aspen Neuroscience, Inc. (ASPE) | Director | 2 | — | — | 4 |
Insider filings — Spaventa Andrew
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-02 | 4 | Aspen Neuroscience, Inc. (ASPE) | Conversion (C): 70,194 · Conversion (C): 180,221 · Conversion (C): 70,194 (derivative) · Conversion (C): 180,221 (derivative) | EDGAR |
| 2026-10-29 | 3 | Aspen Neuroscience, Inc. (ASPE) | Holdings only — no transactions reported | EDGAR |
| 2025-02-25 | 4 | Singular Genomics Systems, Inc. (OMIC) | Disposition to issuer (D): 325 · Disposition to issuer (D): 5,271 · Disposition to issuer (D): 137,629 · Disposition to issuer (D): 85 · Disposition to issuer (D): 42,881 (derivative) @ $1.10 · Disposition to issuer (D): 33,333 (derivative) @ $0 · +3 more | EDGAR |
| 2025-02-14 | 4 | Singular Genomics Systems, Inc. (OMIC) | Option exercise (M): 1,907 · Sale (S): 800 @ $19.89 · Gift (G): 1,107 @ $0 · Gift (G): 1,107 @ $0 · Option exercise (M): 1,907 (derivative) @ $0 | EDGAR |
| 2024-12-17 | 4 | Singular Genomics Systems, Inc. (OMIC) | Option exercise (M): 486 · Sale (S): 180 @ $20.16 · Gift (G): 306 @ $0 · Gift (G): 306 @ $0 · Option exercise (M): 486 (derivative) @ $0 | EDGAR |
| 2024-11-13 | 4 | Singular Genomics Systems, Inc. (OMIC) | Option exercise (M): 1,907 · Sale (S): 695 @ $22.55 · Gift (G): 1,212 @ $0 · Gift (G): 1,212 @ $0 · Option exercise (M): 1,907 (derivative) @ $0 | EDGAR |
| 2024-09-17 | 4 | Singular Genomics Systems, Inc. (OMIC) | Option exercise (M): 487 · Sale (S): 175 @ $12.38 · Gift (G): 312 @ $0 · Gift (G): 312 @ $0 · Option exercise (M): 487 (derivative) @ $0 | EDGAR |
| 2024-08-14 | 4 | Singular Genomics Systems, Inc. (OMIC) | Option exercise (M): 1,906 · Tax withholding (F): 681 @ $7.12 · Gift (G): 1,225 @ $0 · Gift (G): 1,225 @ $0 · Option exercise (M): 1,906 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Singular Genomics Systems, Inc. (OMIC) | Option exercise (M): 14,584 · Gift (G): 14,584 @ $0 · Gift (G): 14,584 @ $0 · Option exercise (M): 14,584 (derivative) @ $0 | EDGAR |
| 2024-05-13 | 4 | Singular Genomics Systems, Inc. (OMIC) | Option exercise (M): 57,188 · Gift (G): 57,188 @ $0 · Gift (G): 57,188 @ $0 · Option exercise (M): 57,188 (derivative) @ $0 | EDGAR |
| 2024-03-19 | 4 | Singular Genomics Systems, Inc. (OMIC) | Option exercise (M): 14,583 · Gift (G): 14,583 @ $0 · Gift (G): 14,583 @ $0 · Option exercise (M): 14,583 (derivative) | EDGAR |
| 2024-02-13 | 4 | Singular Genomics Systems, Inc. (OMIC) | Grant/award (A): 915,000 (derivative) @ $0 | EDGAR |
| 2023-12-18 | 4 | Singular Genomics Systems, Inc. (OMIC) | Option exercise (M): 14,583 · Gift (G): 14,583 @ $0 · Gift (G): 14,583 @ $0 · Option exercise (M): 14,583 (derivative) | EDGAR |
| 2023-11-20 | 4 | Singular Genomics Systems, Inc. (OMIC) | Purchase (P): 43,468 @ $0.41 · Purchase (P): 75,000 @ $0.42 | EDGAR |
| 2023-09-15 | 4 | Singular Genomics Systems, Inc. (OMIC) | Option exercise (M): 14,584 · Gift (G): 14,584 @ $0 · Gift (G): 14,584 @ $0 · Option exercise (M): 14,584 (derivative) | EDGAR |
| 2023-06-20 | 4 | Singular Genomics Systems, Inc. (OMIC) | Option exercise (M): 14,583 · Gift (G): 14,583 @ $0 · Gift (G): 14,583 @ $0 · Option exercise (M): 14,583 (derivative) | EDGAR |
| 2023-03-17 | 4 | Singular Genomics Systems, Inc. (OMIC) | Grant/award (A): 233,333 (derivative) @ $0 · Grant/award (A): 466,667 (derivative) @ $0 | EDGAR |
| 2022-03-24 | 4 | Singular Genomics Systems, Inc. (OMIC) | Other (J): 173,144 · Other (J): 9,766 | EDGAR |
| 2022-03-08 | 4 | Singular Genomics Systems, Inc. (OMIC) | Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
| 2021-12-06 | 4 | Singular Genomics Systems, Inc. (OMIC) | Other (J): 715,884 | EDGAR |
| 2021-06-01 | 4 | Singular Genomics Systems, Inc. (OMIC) | Conversion (C): 715,884 · Conversion (C): 173,144 @ $17.60 · Conversion (C): 362,266 (derivative) · Conversion (C): 201,155 (derivative) · Conversion (C): 152,463 (derivative) · Conversion (C): 173,144 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-05-24 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1859701 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs